Ubrelvy 100 MG tablet UD 16S
Ended Awarded Last action
- Contract number
- SPE2DR26FG3MM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,149
Award facts
- Contract value 100% obligated
- $47,149.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 16, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency, provides $47,149 in firm fixed-price funding for UBRELVY 100 mg tablets in unit dose packages of 16. The contract, which has no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 20, 2026. UBRELVY (ubrogepant) is an acute migraine treatment medication commonly used in military and federal healthcare settings to address headache disorders among service members and beneficiaries.
This delivery order operates under AmerisourceBergen's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (valued at $999.999 billion through December 2026), which serves as the primary procurement vehicle for pharmaceutical products and medical supplies supporting military healthcare programs worldwide. AmerisourceBergen's role as a critical pharmaceutical distributor enables efficient fulfillment of federal medical supply requirements across multiple therapeutic domains, including specialty medications, generic drugs, and medical devices distributed to military treatment facilities, the Defense Health Agency, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FG3MM?
SPE2DR26FG3MM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FG3MM worth?
The government has obligated $47,149 on SPE2DR26FG3MM.
Is contract SPE2DR26FG3MM an order under another contract?
Yes. SPE2DR26FG3MM is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3MM competed?
The extent of competition for SPE2DR26FG3MM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award